WAVED Medical
Revolutionizing breast health with innovative technology
We are developing computational analysis technology to identify at-risk dense breast tissue to assist radiologists in making more informed screening decisions.

The Challenge
Dense breast tissue affects nearly half of all women undergoing mammography screening. This tissue type not only increases cancer risk but also presents challenges during screening, as it can obscure visualization on traditional mammograms, potentially leading to later-stage detection when treatment options are more complex.
Our Solution
WAVED’s patented computational approach is being developed to analyze mammographic images and identify specific patterns in at-risk dense breast tissue. Unlike black box AI approaches that lack transparency, our interpretable methodology allows radiologists to understand how tissue analysis is performed. Our research focuses on creating add-on software that would work with existing mammography systems to provide radiologists with additional analytical information for screening decisions.
The Impact of Breast Cancer Worldwide
- 2.3 million diagnosed
2.3 million women are diagnosed with breast cancer each year*.
- 670,000 deaths
670,000 women die annually from breast cancer*.
- 50%
Of women diagnosed with breast cancer do not have an identifiable risk factor*.
*According to the World Health Organization
Research & Funding Partners
Recent Recognition

Andre Khalil’s research uses imaging techniques to transcend disciplines
University of Maine features Dr. Khalil’s groundbreaking work in computational image analysis and its applications across multiple scientific domains… READ MORE

Fifth cohort of MIRTA accelerator teams wraps up work
WAVED Medical participated in the University of Maine’s prestigious MIRTA accelerator program, developing interpretable analysis tools for breakthrough technologies… READ MORE



